Relx (NYSE:RELX – Get Free Report) and Akso Health Group (NASDAQ:AHG – Get Free Report) are both computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, risk, analyst recommendations, earnings and institutional ownership.
Volatility & Risk
Relx has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500. Comparatively, Akso Health Group has a beta of 0.21, meaning that its share price is 79% less volatile than the S&P 500.
Analyst Recommendations
This is a summary of recent recommendations and price targets for Relx and Akso Health Group, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Relx | 0 | 1 | 0 | 1 | 3.00 |
Akso Health Group | 0 | 0 | 0 | 0 | 0.00 |
Institutional & Insider Ownership
15.0% of Relx shares are owned by institutional investors. Comparatively, 1.2% of Akso Health Group shares are owned by institutional investors. 0.0% of Relx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Earnings & Valuation
This table compares Relx and Akso Health Group”s revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Relx | $9.30 billion | 9.27 | $2.22 billion | N/A | N/A |
Akso Health Group | $2.41 million | 83.29 | -$9.46 million | N/A | N/A |
Relx has higher revenue and earnings than Akso Health Group.
Profitability
This table compares Relx and Akso Health Group’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Relx | N/A | N/A | N/A |
Akso Health Group | N/A | N/A | N/A |
Summary
Relx beats Akso Health Group on 7 of the 8 factors compared between the two stocks.
About Relx
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides information and data sets that help researchers and healthcare professionals to advance science and health outcomes. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and complete transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
About Akso Health Group
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.